These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 38331557)

  • 1. Pluripotent stem cell-based cardiac regenerative therapy for heart failure.
    Soma Y; Tani H; Morita-Umei Y; Kishino Y; Fukuda K; Tohyama S
    J Mol Cell Cardiol; 2024 Feb; 187():90-100. PubMed ID: 38331557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Scalable manufacturing of clinical-grade differentiated cardiomyocytes derived from human-induced pluripotent stem cells for regenerative therapy.
    Morita Y; Kishino Y; Fukuda K; Tohyama S
    Cell Prolif; 2022 Aug; 55(8):e13248. PubMed ID: 35534945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Present State and Future Perspectives of Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells.
    Soma Y; Morita Y; Kishino Y; Kanazawa H; Fukuda K; Tohyama S
    Front Cardiovasc Med; 2021; 8():774389. PubMed ID: 34957258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac muscle patches containing four types of cardiac cells derived from human pluripotent stem cells improve recovery from cardiac injury in mice.
    Lou X; Tang Y; Ye L; Pretorius D; Fast VG; Kahn-Krell AM; Zhang J; Zhang J; Qiao A; Qin G; Kamp T; Thomson JA; Zhang J
    Cardiovasc Res; 2023 May; 119(4):1062-1076. PubMed ID: 36647784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a novel two-dimensional directed differentiation system for generation of cardiomyocytes from human pluripotent stem cells.
    Moon SH; Ban K; Kim C; Kim SS; Byun J; Song MK; Park IH; Yu SP; Yoon YS
    Int J Cardiol; 2013 Sep; 168(1):41-52. PubMed ID: 23044428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A massive suspension culture system with metabolic purification for human pluripotent stem cell-derived cardiomyocytes.
    Hemmi N; Tohyama S; Nakajima K; Kanazawa H; Suzuki T; Hattori F; Seki T; Kishino Y; Hirano A; Okada M; Tabei R; Ohno R; Fujita C; Haruna T; Yuasa S; Sano M; Fujita J; Fukuda K
    Stem Cells Transl Med; 2014 Dec; 3(12):1473-83. PubMed ID: 25355733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Regenerative Therapy Using Human Pluripotent Stem Cells for Heart Failure: A State-of-the-Art Review.
    Kishino Y; Tohyama S; Morita Y; Soma Y; Tani H; Okada M; Kanazawa H; Fukuda K
    J Card Fail; 2023 Apr; 29(4):503-513. PubMed ID: 37059512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Matured Human Pluripotent Stem Cell-Derived Cardiomyocytes Form Grafts With Enhanced Structure and Function in Injured Hearts.
    Dhahri W; Sadikov Valdman T; Wilkinson D; Pereira E; Ceylan E; Andharia N; Qiang B; Masoudpour H; Wulkan F; Quesnel E; Jiang W; Funakoshi S; Mazine A; Gomez-Garcia MJ; Latifi N; Jiang Y; Huszti E; Simmons CA; Keller G; Laflamme MA
    Circulation; 2022 May; 145(18):1412-1426. PubMed ID: 35089805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expandable human cardiovascular progenitors from stem cells for regenerating mouse heart after myocardial infarction.
    Schwach V; Gomes Fernandes M; Maas S; Gerhardt S; Tsonaka R; van der Weerd L; Passier R; Mummery CL; Birket MJ; Salvatori DCF
    Cardiovasc Res; 2020 Mar; 116(3):545-553. PubMed ID: 31287499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transplantation of Human Pluripotent Stem Cell-Derived Cardiomyocytes for Cardiac Regenerative Therapy.
    Silver SE; Barrs RW; Mei Y
    Front Cardiovasc Med; 2021; 8():707890. PubMed ID: 34820426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism-based cardiomyocytes production for regenerative therapy.
    Umei TC; Tohyama S; Fukuda K
    J Mol Cell Cardiol; 2023 Mar; 176():11-20. PubMed ID: 36681267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Strategies and Challenges for Purification of Cardiomyocytes Derived from Human Pluripotent Stem Cells.
    Ban K; Bae S; Yoon YS
    Theranostics; 2017; 7(7):2067-2077. PubMed ID: 28638487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation of human induced pluripotent stem cell-derived cardiomyocytes improves myocardial function and reverses ventricular remodeling in infarcted rat hearts.
    Guan X; Xu W; Zhang H; Wang Q; Yu J; Zhang R; Chen Y; Xia Y; Wang J; Wang D
    Stem Cell Res Ther; 2020 Feb; 11(1):73. PubMed ID: 32085809
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graft-host coupling changes can lead to engraftment arrhythmia: a computational study.
    Gibbs CE; Marchianó S; Zhang K; Yang X; Murry CE; Boyle PM
    J Physiol; 2023 Jul; 601(13):2733-2749. PubMed ID: 37014103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of functional cardiomyocytes and cardiac tissue from human induced pluripotent stem cells for regenerative therapy.
    Tani H; Tohyama S; Kishino Y; Kanazawa H; Fukuda K
    J Mol Cell Cardiol; 2022 Mar; 164():83-91. PubMed ID: 34822838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive Stretch Induces Structural and Functional Maturation of Engineered Heart Muscle as Predicted by Computational Modeling.
    Abilez OJ; Tzatzalos E; Yang H; Zhao MT; Jung G; Zöllner AM; Tiburcy M; Riegler J; Matsa E; Shukla P; Zhuge Y; Chour T; Chen VC; Burridge PW; Karakikes I; Kuhl E; Bernstein D; Couture LA; Gold JD; Zimmermann WH; Wu JC
    Stem Cells; 2018 Feb; 36(2):265-277. PubMed ID: 29086457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional Effects of a Tissue-Engineered Cardiac Patch From Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in a Rat Infarct Model.
    Wendel JS; Ye L; Tao R; Zhang J; Zhang J; Kamp TJ; Tranquillo RT
    Stem Cells Transl Med; 2015 Nov; 4(11):1324-32. PubMed ID: 26371342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transferrin improved the generation of cardiomyocyte from human pluripotent stem cells for myocardial infarction repair.
    Zhang F; Qiu H; Dong X; Wang C; Na J; Zhou J; Wang C
    J Mol Histol; 2021 Feb; 52(1):87-99. PubMed ID: 33179120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.